Mirikizumab Effective in Crohn's Disease After Initial Standard Therapy Failure

(MedPage Today) -- Mirikizumab (Omvoh) improved outcomes in patients with moderately-to-severely active Crohn's disease with previous failure to standard therapy, a phase III randomized trial showed.
Among over 1,000 patients in the efficacy population...